Engagement Optimization Unit

参与度优化单元

基本信息

项目摘要

ABSTRACT: ENGAGEMENT OPTIMIZATION UNIT (EOU) With advances in molecular genomics, we have an improved understanding of the drivers of tumor evolution and therapy response, yet inclusion of Hispanic/Latino CRC patients in these studies has been minimal. Moreover, there are virtually no empirical data to inform best practices for educating, consenting, enrolling and retaining H/L patients in cancer genomics investigations, nor are there culturally, language, literacy and numeracy appropriate tools to utilize to reach these patients or to facilitate interpretation of data they receive. A better understanding of how H/Ls understand, value and communicate genomics-related information is the essential foundation for rigorous research to optimize patient engagement and outcomes. The Engagement Optimization Unit (EOU) will fill these gaps by conducting rigorous research to generate evidence-based best practices and by validating culturally specific tools for optimizing Hispanic/Latino patient engagement and empowerment. This will be accomplished via an iterative process of experimentation, evaluation, implementation and re-evaluation in a study population at LAC+USC and Norris of 275 H/L participants with metastatic CRC, as well as a separate cohort of 500 H/L participants with CRC (both newly diagnosed and survivors) who will be engaged in genomic sequencing and follow up. The Specific Aims are: (1) to assess the educational and communication needs of H/L CRC patients related to participation in cancer genomics research; and evaluate the role of language, acculturation, numeracy and health literacy; (2) to develop best practices for engagement of H/L CRC patients in informed consent for genomic characterization; (3) to determine the most efficacious strategies to communicate genomic results to H/L CRC patients; and (4) to develop and test a comprehensive tool kit (The Hispanic/Latino Genomic Engagement through Narrative Empowerment Tool Kit (H/L G.E.N.E.)) for use by promotores de salud (community health workers) and other providers with the purpose of optimizing H/L engagement, enhancing recruitment and strengthening retention of H/L patients into cancer genomics research.
摘要:敬业度优化单元 (EOU) 随着分子基因组学的进步,我们对肿瘤进化的驱动因素有了更深入的了解, 治疗反应,但这些研究中西班牙裔/拉丁裔 CRC 患者的纳入人数很少。而且, 实际上没有经验数据来指导教育、同意、注册和保留的最佳做法 H/L患者进行癌症基因组学研究,也不存在文化、语言、识字和算术能力 使用适当的工具来接触这些患者或促进他们收到的数据的解释。更好的 了解 H/L 如何理解、重视和交流基因组学相关信息至关重要 为优化患者参与和结果的严格研究奠定了基础。参与度优化 单位(EOU)将通过进行严格的研究来填补这些空白,以产生基于证据的最佳实践和 通过验证特定文化的工具来优化西班牙裔/拉丁裔患者的参与和赋权。这 将通过实验、评估、实施和再评估的迭代过程来完成 在 LAC+USC 和 Norris 进行的一项研究人群中,有 275 名患有转移性 CRC 的 H/L 参与者,以及一项单独的研究 由 500 名患有 CRC 的 H/L 参与者(包括新诊断的和幸存者)组成的队列,他们将从事基因组研究 排序和跟进。具体目标是: (1) 评估学生的教育和交流需求 与参与癌症基因组学研究相关的 H/L CRC 患者;并评估语言的作用, 文化适应、算术和健康素养; (2) 制定 H/L CRC 患者参与的最佳实践 基因组表征的知情同意书; (3) 确定最有效的策略 向 H/L CRC 患者传达基因组结果; (4) 开发和测试综合工具包(The 通过叙事赋权工具套件 (H/L G.E.N.E.) 进行西班牙裔/拉丁裔基因组参与)供以下人员使用 promotores de salud(社区卫生工作者)和其他以优化 H/L 为目的的提供者 参与、加强招募和加强 H/L 患者对癌症基因组学研究的保留。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

LOURDES A. BAEZCONDE-GARBANATI其他文献

LOURDES A. BAEZCONDE-GARBANATI的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('LOURDES A. BAEZCONDE-GARBANATI', 18)}}的其他基金

Engagement Optimization Unit
参与度优化单元
  • 批准号:
    10294888
  • 财政年份:
    2021
  • 资助金额:
    $ 100.52万
  • 项目类别:
Engagement Optimization Unit
参与度优化单元
  • 批准号:
    10696246
  • 财政年份:
    2021
  • 资助金额:
    $ 100.52万
  • 项目类别:
Outreach Core
外展核心
  • 批准号:
    10006128
  • 财政年份:
    2018
  • 资助金额:
    $ 100.52万
  • 项目类别:
Outreach Core
外展核心
  • 批准号:
    10762323
  • 财政年份:
    2018
  • 资助金额:
    $ 100.52万
  • 项目类别:
Outreach Core
外展核心
  • 批准号:
    10252800
  • 财政年份:
    2018
  • 资助金额:
    $ 100.52万
  • 项目类别:
Outreach Core
外展核心
  • 批准号:
    10481856
  • 财政年份:
    2018
  • 资助金额:
    $ 100.52万
  • 项目类别:
Partners for Strong, Healthy Families (PSHF)
坚强、健康家庭的合作伙伴 (PSHF)
  • 批准号:
    8499684
  • 财政年份:
    2013
  • 资助金额:
    $ 100.52万
  • 项目类别:
Partners for Strong, Healthy Families (PSHF)
坚强、健康家庭的合作伙伴 (PSHF)
  • 批准号:
    8717718
  • 财政年份:
    2013
  • 资助金额:
    $ 100.52万
  • 项目类别:
Transforming Cancer Knowledge, Attitudes and Behavior through Narrative
通过叙事改变癌症知识、态度和行为
  • 批准号:
    8325165
  • 财政年份:
    2009
  • 资助金额:
    $ 100.52万
  • 项目类别:
Transforming Cancer Knowledge, Attitudes and Behavior through Narrative
通过叙事改变癌症知识、态度和行为
  • 批准号:
    7765605
  • 财政年份:
    2009
  • 资助金额:
    $ 100.52万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 100.52万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 100.52万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 100.52万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 100.52万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 100.52万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 100.52万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 100.52万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 100.52万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 100.52万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 100.52万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了